7b, a novel naphthalimide derivative, exhibited anti-inflammatory effects via targeted-inhibiting TAK1 following down-regulation of ERK1/2- and p38 MAPK-mediated activation of NF-κB in LPS-stimulated RAW264.7 macrophages
- 1 October 2013
- journal article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 17 (2), 216-228
- https://doi.org/10.1016/j.intimp.2013.06.008
Abstract
No abstract availableKeywords
Funding Information
- Fundamental Research Funds for the Central Universities and Shanghai Committee of Science and Technology (11DZ2260600)
This publication has 51 references indexed in Scilit:
- NF-κB signaling pathways regulated by CARMA family of scaffold proteinsCell Research, 2010
- Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implicationsBiochimie, 2010
- Immunity, Inflammation, and CancerCell, 2010
- The Nuclear Factor NF- B Pathway in InflammationCold Spring Harbor Perspectives in Biology, 2009
- Activation of NF-kB Pathway by Virus Infection Requires Rb ExpressionPLOS ONE, 2009
- TGF-β coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survivalExperimental Cell Research, 2008
- Shared Principles in NF-κB SignalingCell, 2008
- Inhibition of inducible nitric oxide synthase and cyclooxygenase‐2 in lipopolysaccharide‐stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down‐regulation of mitogen‐activated protein kinase‐mediated nuclear factor‐κB signalingImmunology, 2008
- PKC412 (CGP41251) modulates the proliferation and lipopolysaccharide-induced inflammatory responses of RAW 264.7 macrophagesBiochemical and Biophysical Research Communications, 2007
- A cytokine-mediated link between innate immunity, inflammation, and cancerJCI Insight, 2007